α1-Antitrypsin CAS NO (9041-92-3) available for sale at cheap price

Introduction to α1-Antitrypsin (9041-92-3)

• α1-Antitrypsin (AAT) is a multifunctional serine protease inhibitor that plays a crucial role in regulating protease activity and maintaining tissue integrity.
• This comprehensive review explores the diverse facets of AAT, including its molecular structure, physiological functions, and clinical significance in health and disease.

Molecular Architecture of α1-Antitrypsin

• AAT is a glycoprotein characterized by a unique tertiary structure comprising multiple β-sheets and α-helices.
• The protein harbors a reactive center loop (RCL) that interacts with target proteases, forming stable enzyme-inhibitor complexes.

Inhibition of Protease Activity

• AAT functions as a potent inhibitor of serine proteases, including neutrophil elastase, cathepsin G, and proteinase 3.
• The reactive center loop of AAT undergoes conformational changes upon protease binding, leading to irreversible inhibition and neutralization of proteolytic activity.

Regulation of Inflammatory Response

• AAT exerts anti-inflammatory effects by suppressing the activity of proteases involved in tissue damage and inflammation.
• The protein modulates immune cell function, cytokine production, and leukocyte recruitment, contributing to the resolution of inflammatory responses.

Physiological Functions of α1-Antitrypsin

• Beyond its role as a protease inhibitor, AAT participates in various physiological processes, including tissue repair, angiogenesis, and lipid metabolism.
• The protein exhibits cytoprotective properties, preserving cell viability and function under conditions of stress and injury.

Genetic Variants and Disease Associations

• Genetic mutations in the SERPINA1 gene encoding AAT are associated with hereditary AAT deficiency, a condition predisposing individuals to lung and liver diseases.
• Homozygous AAT deficiency increases the risk of emphysema and chronic obstructive pulmonary disease (COPD), while liver involvement may manifest as cirrhosis and hepatocellular carcinoma.

Diagnostic and Therapeutic Implications

• Measurement of serum AAT levels serves as a diagnostic marker for AAT deficiency and related disorders.
• Augmentation therapy with exogenous AAT protein is utilized to restore protease-antiprotease balance in individuals with AAT deficiency and mitigate disease progression.

Role in Lung Disease Pathogenesis

• AAT deficiency-associated lung diseases, such as emphysema and COPD, result from unchecked protease activity and tissue destruction in the respiratory tract.
• Therapeutic interventions targeting AAT deficiency aim to preserve lung function, alleviate symptoms, and improve quality of life in affected individuals.

Emerging Therapeutic Strategies

• Novel therapeutic approaches, including gene therapy and small molecule inhibitors, are being investigated for the treatment of AAT deficiency and related disorders.
• Advances in precision medicine and personalized therapy hold promise for tailored interventions targeting specific disease mechanisms and genetic variants.

Conclusion: Safeguarding Tissue Integrity with α1-Antitrypsin

• α1-Antitrypsin emerges as a guardian of tissue integrity, orchestrating protease regulation and immune modulation to preserve organ function and health.
• Continued research efforts aim to deepen our understanding of AAT biology and leverage its therapeutic potential for the management of inflammatory and genetic diseases affecting lung and liver tissues.